We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
18.00 | 0.16% | 11,268.00 | 11,222.00 | 11,226.00 | 11,362.00 | 11,220.00 | 11,250.00 | 3,556,178 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 29.21 | 173.96B |
Date | Subject | Author | Discuss |
---|---|---|---|
11/1/2022 17:50 | hTTps://brandnewtube | aidenabettin | |
11/1/2022 17:38 | You never ever mass vaccinate during a pandemic . I'm a nutter for calling for a halt to vaccination and especially the pfizer/moderna mRNA gene therapy booster . The WHO now agrees . Who is crazy? | aidenabettin | |
11/1/2022 17:28 | hTTps://www.dailysab | aidenabettin | |
11/1/2022 17:21 | No keep talking aids a bettin and (show me the way) to jimarilo, your diatribe has just raised the price by 142p today ! Great reading, need a good laugh now and again. | peterev4 | |
11/1/2022 10:49 | Ffs give us a break | riskonricky | |
11/1/2022 10:18 | My new accommodation being set up. hTTps://brandnewtube | aidenabettin | |
11/1/2022 10:03 | Thought you'd fu-coughed already aiden. So bored or you guys trolling | riskonricky | |
11/1/2022 09:59 | Many are now refusing experimental boosters drugs and vaccines.Vaccine related deaths will become the #1 cause of death over the next year Imo | aidenabettin | |
10/1/2022 12:40 | "First UKHSA Vaccine Surveillance Report of 2022. Last 4 weeks of 2021: 65% of adult "Covid hospitalisations" were vaccinated. 72% of "Covid deaths" were vaccinated. Anyone, and I mean anyone, who says the vast majority are unjabbed is lying to you." | jimarilo | |
10/1/2022 09:45 | And now, albeit a little late some news on AZN. Exclusive Speaker Interview with Karen Capper, AstraZeneca Ahead of the Pharmaceutical Microbiology UK Virtual Conference 01/08/2022 | 08:01am GMT SMi Group reports: exclusive speaker interview with microbiology expert Karen Capper, AstraZeneca about the developments in the microbiology field. London, United Kingdom January 08, 2022 --(PR.com)-- Now in its 10th Annual year, the Pharmaceutical Microbiology UK conference is taking place on 17th and 18th January 2022 as a virtual conference with online access only. The conference will bring together industry experts to discuss and analyse the latest advancements and challenges within pharmaceutical microbiology. Interested parties can register for the conference and the two interactive workshops at hxxp://www.pharma-mi Ahead of the virtual conference taking place in less than two weeks, SMi Group caught up with Karen Capper, Associate Director - Head of Microbiology, Pharmaceutical Development, AstraZeneca. Below is the excerpts of the interview: SMi Group - The industry surrounding pharmaceutical microbiology is maturing each year, in your opinion, what are some of the most major developments that have taken place in the last year? Karen Capper, "The need to act quickly through the pandemic has enabled more acceptance of rapid methods and new technology in microbiology. The microbiologists need to ensure this momentum is maintained and the industry continues to use some of this technology for pharmaceutical products." SMi Group - What topic will you be presenting on at the conference, and what would you say makes it especially important in 2022? Karen Capper - "I will be presenting on the use of Virtual Technology for Microbiology and Aseptic training. The use of this type of technology enables a faster capability uplift of staff whilst reducing the burden on the facility and microbiology laboratories. The increase in the need for aseptic and microbiology staff through the pandemic has made this a very useful tool for future training." SMi Group What are your thoughts on the shifting regulatory environment, and how is this currently impacting your role? Karen Capper - "The main impacts I see in the regulatory environment is managing the various market requirements whilst running an efficient business. The need to comply with more rest of the world markets has led to complexity in method development and acceptance." To read the full interview visit the download centre on the conference website to read the full interview at hxxp://www.pharma-mi Karen Capper will be presenting on day two of the Pharmaceutical Microbiology UK Virtual Conference along with Suzanne Nutter, QA Group Manager, AstraZeneca on: “Applying Virtual Reality To Training In Aseptic Processing & Microbiology" which will cover: • Overview of the technology • Rollout plan and approach • Pros and cons of the technology for training The conference is proudly sponsored by ECOLAB and Microgenetics For media enquiries and press pass requests, contact Simi Sapal, Head of Marketing on +44 (0) 20 7827 6162 or ssapal@smi-online.co SMi’s 10th Annual Pharmaceutical Microbiology Conference Conference: 17 - 18 January 2022 Workshops: 19 January 2022 Virtual Conference: Online Access Only hxxp://www.pharma-mi #SMiPharmaMicroUK About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at hxxp://www.smi-onlin Contact Information: SMi Group Simi Sapal (0) 20 7827 6162 Contact via Email hxxp://www.pharma-mi Read the full story here: hxxps://www.pr.com/p Press Release Distributed by PR.com Copyright © 2022 PR.com and its licensors , source US Press Releases | beckers2008 | |
09/1/2022 15:46 | No problem m8 | riskonricky | |
09/1/2022 12:19 | Bye bye scum bag | riskonricky | |
09/1/2022 12:19 | Come on, say bye bye | riskonricky | |
09/1/2022 12:19 | Say bye bye aiden | riskonricky | |
09/1/2022 12:18 | You go now aiden | riskonricky | |
09/1/2022 10:44 | hTTps://brandnewtube | aidenabettin | |
09/1/2022 09:15 | Bye bye aiden | riskonricky | |
09/1/2022 09:15 | Time for you to go now | riskonricky |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions